Nonhematologic toxicities by day 100
| Adverse event . | Patients with an event (n = 30) . | ||
|---|---|---|---|
| Grade II, no. (%) of events . | Grade III, no. (%) of events . | Grade IV, no. (%) of events . | |
| CNS toxicity/confusion | 4 (12) | 3 (9) | 0 |
| Pulmonary | 0 | 5 (15) | 0 |
| Gastrointestinal | 1 (3) | 3 (9) | 0 |
| Renal failure | 0 | 3 (9) | 0 |
| Bladder toxicity | 1 (3) | 2 (6) | 0 |
| Hepatic | 3 (9) | 1 (3) | 0 |
| Cardiac | 2 (6) | 1 (3) | 0 |
| Mucositis (Bearman) | 17 (52) | 0 | 0 |
| Adverse event . | Patients with an event (n = 30) . | ||
|---|---|---|---|
| Grade II, no. (%) of events . | Grade III, no. (%) of events . | Grade IV, no. (%) of events . | |
| CNS toxicity/confusion | 4 (12) | 3 (9) | 0 |
| Pulmonary | 0 | 5 (15) | 0 |
| Gastrointestinal | 1 (3) | 3 (9) | 0 |
| Renal failure | 0 | 3 (9) | 0 |
| Bladder toxicity | 1 (3) | 2 (6) | 0 |
| Hepatic | 3 (9) | 1 (3) | 0 |
| Cardiac | 2 (6) | 1 (3) | 0 |
| Mucositis (Bearman) | 17 (52) | 0 | 0 |
All reported toxicities are based on the Bearman scale.27
CNS indicates central nervous system.